BTIG will host its first Obesity Health Forum on Wednesday, May 8, 2024. Industry-leading biotechnology firms, digital health companies with a focus on treating obesity and policymakers will be participating in the firm’s virtual event which will include thematic panels and fireside chats. The forum will be hosted by:

• Justin Zelin, BTIG Biotechnology Analyst
• David Larsen, CFA, BTIG Digital Health Analyst
• Julian Harrison, BTIG Biotechnology Analyst
• Isaac Boltansky, BTIG Directory of Policy Research

“The development and delivery of effective obesity care has brought a shift to healthcare with broad reaching implications for every sector,” said Justin Zelin, BTIG Biotechnology Analyst. “Our event will provide a forum for BTIG’s institutional investor clients to explore emerging innovations, discuss latest trends and see what’s on the horizon.”

More than 19 public and private healthcare companies will be participating in the event. Panel discussion topics will include:

• Obesity management with coaching, eating, and lifestyle management
• GLP-1s are great but how do we pay for them?
• How Employers View GLP-1s, Obesity Management, and the ROI for Employees
• Bringing Scale and Leverage to the GLP-1 Market
• Fireside Chat with the Office of Congressman Brad Wenstrup (R-OH)
• The Latest Developments in Obesity Treatment
• CB1 Axis Therapies of Obesity
• Emerging Therapeutics Panel

The conference is being produced by BTIG’s Corporate Access program which hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate and technology sectors. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclosures/general-disclaimer/. To learn more about BTIG, visit www.btig.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508590702/en/